Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in advanced GIST
NCT01271712Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of regorafenib in gastrointestinal stromal tumor (GIST), sponsored by Bayer. Started Jan 2011; status: completed.
02
Drugs
regorafenib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01271712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271712.